Table 2. TCR-BV sequences identified in brain tissue, CSF cells, and sorted peripheral blood cells (PBL) from Patient A by CDR3 spectratyping.
TCR-BV CDR3 sequence | Brain 1996 | CSF 2001 | CD4+ PBL 2001 | CD8+ PBL 2001 | CD38+ PBL 2001 |
---|---|---|---|---|---|
BV9 - C A S S - P W E E G - S G N - BJ1.3 | + | + | - | - | - |
BV9 - C A S S - Q I R G V G - E Q Y - BJ2.7 | + | (+)# | - | - | + |
BV16 - C A S - G G T S G K - D T Q - BJ2.3 | + | (+) | - | - | - |
BV17 - C A S S - W A I S D R - Q P Q - BJ1.5 | + | (+) | - | - | - |
The N-D-N regions are shown in italics, +, completely readable sequence; (+), clonal identity clearly discernible on an oligoclonal background; (+)#, completely readable sequence with clone-specific primer; -, clone not identifiable by CDR3 spectratyping and/or direct sequencing. Note that the TCR sequences observed at different sites and time points were identical both at the nucleotide and amino acid levels